Earnings Preview: Scholar Rock to Report Financial Results Pre-market on May 14
Press Release: Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025
Express News | Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025
LifeSci Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $49
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $45
Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Compass Therapeutics (CMPX)
Scholar Rock Names Chair David Hallal as New CEO Taling Over From Jay Backstrom
Express News | Scholar Rock Holding Corp - Vikas Sinha Appointed as CFO
Scholar Rock Holding: R. Keith Woods Appointed to Newly Created Role of Operating Chief >SRRK
Express News | Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
Piper Sandler Maintains Scholar Rock(SRRK.US) With Buy Rating
Why Scholar Rock Holding Stock Topped the Market Today
Piper Sandler Remains a Buy on Scholar Rock Holding (SRRK)
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Scholar Rock Holding Corporation's (NASDAQ:SRRK) Profit Outlook
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Announces Target Price $45
Insider Sale: Chief Commercial Officer of $SRRK Sells 5,000 Shares
Scholar Rock Application for Spinal Muscular Atrophy Treatment Gets FDA Approval
Scholar Rock Announces FDA Priority Review Designation For Apitegromab - Quick Facts